Travere Therapeutics Inc (TVTX) — Cash Flow Quality Index
Travere Therapeutics Inc (TVTX) has a Cash Flow Quality Index of 0.56x as of September 2025. Operating cash flow of $14.32 Million is below net income of $25.71 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore TVTX long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Travere Therapeutics Inc Cash Flow Quality Index (2015–2015)
Historical Cash Flow Quality Index for Travere Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Travere Therapeutics Inc to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Travere Therapeutics Inc (2015–2015)
Year-by-year earnings quality comparison for Travere Therapeutics Inc. For live market cap and the full company financial profile, see Travere Therapeutics Inc (TVTX) market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2015 | 0.00x | $-554.00K | $117.24 Million | — |